==referencias====enlaces externos==*fda approval for peramivir*peramivir: requirements for administration under eua*biocryst pharmaceuticals, inc.*peramivir cdc/fda eua request form*peramivir phase iii clinical trials*peramivir emergency use authorization disposition letter and question and answer attachment*a novel anti-viral drug for influenza, rapiacta launch
Engelska
==references====external links==*fda approval for peramivir*peramivir: requirements for administration under eua*biocryst pharmaceuticals, inc.*peramivir cdc/fda eua request form*peramivir phase iii clinical trials*peramivir emergency use authorization disposition letter and question and answer attachment*a novel anti-viral drug for influenza, rapiacta launch
Vi använder cookies för att förbättra din upplevelse. Genom att fortsätta besöka den här webbplatsen godkänner du vår användning av cookies. Läs mer.OK